Guest guest Posted July 8, 2011 Report Share Posted July 8, 2011 Inovio expands DNA vaccine technology license with U Penn Proactive Investors USA & Canada Under the terms of the original license agreement completed in 2007, Inovio obtained exclusive worldwide rights to develop multiple DNA vaccines with the potential to treat and/or prevent HIV, hepatitis C virus, HPV and related diseases, ... See all stories on this topic » Drug Breakthrough Gives New Hope to Hepatitis C Victims SanDiego.com Hepatitis C, an infectious disease affecting the liver can be asymptomatic for years. Typically, it is discovered by accident during routine checkups or doctor visits. Four times more common than HIV/AIDS, hepatitis C is curable; but left unchecked, ... See all stories on this topic » Hepatitis C on the rise in northern Wisconsin Superior Telegram Wisconsin health officials want to learn why cases of Hepatitis C have increased dramatically among young adults in six north central counties. Wisconsin health officials want to learn why cases of Hepatitis C have increased dramatically among young ... See all stories on this topic » ABL DeepChek™ Using High-Throughput Sequencing Systems Aids in the Generation .... Business Wire (press release) ABL, Roche Diagnostics Spain and CIBERHED, a network of liver diseases specialists in Spain, have recently announced their collaboration on the development of a complete high-throughput sequencing-DeepChek™-HEP solution for viral hepatitis infections ... See all stories on this topic »J & J's Been Busy Motley Fool And yesterday, & announced it was hooking up with a different partner, Pharmasset (Nasdaq: VRUS ) , to create a hepatitis C drug combo. The duo plan to run a phase 2 trial combining the companies' experimental drug candidates: PSI-7977 ... See all stories on this topic »HFF arranges $355m in financing for Fan Pier Boston Globe The company's expansion plans were conditioned on getting approval from the Food and Drug Administration for Vertex's hepatitis C treatment that will be marketed under the name of Incivek. That approval was granted in May. Incivek has the potential to ... See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.